大梗死核心且缺血半暗带有限患者的卒中取栓治疗:随机试验的系统综述与Meta分析
该系统综述与Meta分析纳入5项随机试验,比较血管内取栓与药物治疗在大梗死核心卒中患者中的疗效,并按灌注不匹配特征分层。中间不匹配组(不匹配比1.2-1.8或半暗带体积10-15cc)取栓与90天mRS 0-3的更高 odds 相关(OR 2.77),低不匹配组(不匹配比<1.2或体积<10cc)无显著获益。
要点
- 中间不匹配组取栓与90天mRS 0-3更高 odds 相关(OR 2.77,95%CI 1.11-6.89,P=.028)。
- 低不匹配组取栓与90天mRS 0-3无显著关联(OR 1.47,95%CI 0.44-4.94,P=.54)。
- 中间不匹配组取栓与90天mRS 5-6更低 odds 相关(OR 0.49,95%CI 0.24-0.99,P=.046)。
核心结论
- 大梗死核心卒中患者中,灌注不匹配比和体积至少为1.2和10cc者取栓有益,而不匹配比<1.2或体积<10cc者无获益。
研究设计与样本
- 系统综述与Meta分析,纳入5项随机对照试验(检索MEDLINE自建库至2024年7月8日),大梗死核心定义为梗死核心体积>50cc或ASPECTS<6,按不匹配特征分层。
诊断标准与关键数值
- 中间不匹配定义为不匹配比1.2-1.8或半暗带体积10-15cc,低不匹配定义为不匹配比<1.2或体积<10cc;中间不匹配组取栓 vs 药物:mRS 0-3的OR 2.77(95%CI 1.11-6.89,P=.028),mRS 5-6的OR 0.49(95%CI 0.24-0.99,P=.046);低不匹配组取栓 vs 药物:mRS 0-3的OR 1.47(95%CI 0.44-4.94,P=.54),mRS 5-6的OR 0.66(95%CI 0.22-1.96,P=.45)。
临床应用与阅片要点
- 对于大梗死核心卒中患者,可依据灌注不匹配比和半暗带体积分层评估取栓获益:不匹配比≥1.2且体积≥10cc者取栓与更好功能结局相关,不匹配比<1.2或体积<10cc者未见显著获益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Recent randomized trials have suggested that endovascular thrombectomy (EVT) is superior to medical management (MM) for stroke patients with large infarcts. However, whether or how perfusion metrics should be used to guide optimal patient selection for treatment is unknown.
PURPOSE: To synthesize trial results to provide more definitive guidance on the role of EVT for stroke patients with large infarcts based on perfusion metrics.
DATA SOURCES: MEDLINE database from inception up to July 8, 2024. Randomized controlled trials that report the efficacy and safety of EVT for patients with large infarcts (defined by either infarct core volume greater than 50cc or Alberta Stroke Program Early CT Score [ASPECTS] less than 6) stratified by mismatch profile were included.
STUDY SELECTION: Five trials were identified - SELECT2 and ANGEL-ASPECT.
DATA ANALYSIS: The primary outcome was odds of acceptable outcomes (90-day modified Rankin scale [mRS] 0 to 3). Secondary outcome was 90-day mRS 5 or 6. Patients where then subdivided into those with mismatch ratio 1.2-1.8 or penumbra volume 10-15cc (intermediate mismatch) and those with mismatch ratio <1.2 or volume <10cc (low mismatch).
DATA SYNTHESIS: A total of 140 intermediate mismatch (75 EVT and 65 MM) and 60 low mismatch patients (23 EVT and 37 MM) were identified. EVT was significantly associated with higher odds of mRS 0-3 for intermediate mismatch (OR 2.77 [95% CI 1.11-6.89], P = .028), but not low mismatch (OR 1.47 [95% CI 0.44-4.94], P = .54). Similarly, in terms of 90-day poor outcomes (mRS 5-6), EVT for intermediate mismatch patients was significantly associated with lower odds (OR 0.49 [95% CI 0.24 to 0.99], P = .046), while EVT for the low mismatch cohort was not (OR 0.66 [95% CI 0.22 to 1.96], P = .45). There was no significant inter-study heterogeneity observed across study estimates.
CONCLUSIONS: For stroke patients with large infarcts, EVT was beneficial for patients with perfusion mismatch ratio and volume of at least 1.2 and 10cc, but not for those with mismatch ratio <1.2 or volume <10cc.
引用
- Chen H, Chaturvedi S, Gandhi D, et al. Stroke Thrombectomy for Large Infarcts with Limited Penumbra: Systematic Review and Meta-Analysis of Randomized Trials. AJNR Am J Neuroradiol. 2025. PMID: 39443149. doi:10.3174/ajnr.A8553
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。